| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 04/02/1996 | US5503993 Expressing and secreting mature human serum albumin by yeast transformed by recombinant dna comprising modified signal peptide gene which encodes modified signal peptide, promoter, terminator linked operably in proper reading frame |
| 04/02/1996 | US5503991 Vectors for use in filamentous fungi |
| 04/02/1996 | US5503987 Immunoassay for metallic cations and small organic molecules |
| 04/02/1996 | US5503983 Incubating eluate with solid support precoated with antibodies washing, incubating second composition of antibodies with said solid support, washing, detecting antibodies bound to solid support |
| 04/02/1996 | US5503981 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 04/02/1996 | US5503976 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and diagnostic typing processes and products related thereto |
| 04/02/1996 | CA2066370C Yield when disulfide-bonded proteins are secreted |
| 03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |
| 03/28/1996 | WO1996009403A1 Enzymatic hydrolysis of 4-methylthiobutyronitriles |
| 03/28/1996 | WO1996009402A1 Copolyesters |
| 03/28/1996 | WO1996009394A1 Nucleic acid fragment and products derived therefrom |
| 03/28/1996 | WO1996009390A2 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/28/1996 | WO1996009386A2 Allelic variation of the serotonin 5ht2c receptor |
| 03/28/1996 | WO1996009382A1 gp130 LACKING THE TRANSMEMBRANE DOMAIN |
| 03/28/1996 | WO1996009375A1 Dna encoding human papillomavirus type 6a |
| 03/28/1996 | WO1996009321A1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 03/28/1996 | WO1996009320A1 Antigenic polypeptide of chlamydia pneumoniae |
| 03/28/1996 | WO1996009311A1 Human transcription factor iia |
| 03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | WO1996009060A1 Cell growth regulator |
| 03/28/1996 | WO1996007749A3 Methods and compositions for inhibiting production of replication competent virus |
| 03/28/1996 | WO1996007738A3 Modified human c3 proteins |
| 03/28/1996 | WO1996005314A3 Protein toxins active against lepidopteran pests |
| 03/28/1996 | WO1996005295A3 An improved cleaning composition |
| 03/28/1996 | DE4441197C1 Schizosaccharomyces pombe expression plasmids |
| 03/28/1996 | CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | CA2200473A1 Copolyesters |
| 03/28/1996 | CA2200357A1 Nucleic acid fragment and products derived therefrom |
| 03/28/1996 | CA2200100A1 Enzymatic hydrolysis of 4-methylthiobutyronitriles |
| 03/28/1996 | CA2199748A1 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/28/1996 | CA2199470A1 Allelic variation of the serotonin 5ht2c receptor |
| 03/28/1996 | CA2159176A1 Process for extraction of carotenoids from bacterial cells |
| 03/27/1996 | EP0702726A1 Immunoassay reagents and methods for detecting brequinar and analogs |
| 03/27/1996 | EP0702725A1 Method for recombinant production of biologically active polypeptides |
| 03/27/1996 | EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides |
| 03/27/1996 | EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 03/27/1996 | EP0702721A1 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
| 03/27/1996 | EP0702717A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 03/27/1996 | EP0702716A1 Ribozyme gene therapy for hiv infection and aids |
| 03/27/1996 | EP0702715A1 CLONING AND EXPRESSION OF THE CHONDROITINASE I AND II GENES FROM $i(P. VULGARIS) |
| 03/27/1996 | EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
| 03/27/1996 | EP0702694A1 $i(PSEUDOMONAS SYRINGAE) pv. $i(SYRINGAE hrpZ) GENE |
| 03/27/1996 | EP0702691A1 New thiodepsipeptide isolated from a marine actinomycete |
| 03/27/1996 | EP0702564A1 Novel attenuated pseudomonas aeruginosa strains |
| 03/27/1996 | EP0483224B1 Inducible expression vectors |
| 03/27/1996 | CN1119459A Process for preparing cancer vaccines |
| 03/27/1996 | CN1119458A Nucleic acid pharmaceuticals |
| 03/27/1996 | CN1119406A Mucosal competitive exclusion flora |
| 03/27/1996 | CN1119121A Crystalline interleukin-4 |
| 03/26/1996 | US5502167 CDR grafted humanised chimeric T-cell antibodies |
| 03/26/1996 | US5502034 Methods for producing thrombin |
| 03/26/1996 | US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases |
| 03/26/1996 | US5501979 Herpes simplex virus type I expression vector |
| 03/26/1996 | US5501975 Transformed host cell, dibasic processing endoprotease, improved yield of correctly folded proteins |
| 03/26/1996 | US5501970 Nucleotide sequences coding for ribosome inactivating proteins |
| 03/26/1996 | US5501966 Pseudomonas aeruginosa and its use in a process for the biotechnological preparation of L-rhamnose |
| 03/26/1996 | US5501853 Peptide plasminogen activators |
| 03/26/1996 | CA1338185C Glycosidase inhibitor salbostatin, process for its preparation, and its use |
| 03/26/1996 | CA1338184C Bu-3862t antitumor antibiotic |
| 03/26/1996 | CA1338183C Cyclic peptolides |
| 03/21/1996 | WO1996008582A2 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 03/21/1996 | WO1996008572A1 Method for the production of recombinant proteins, plasmids and modified cells |
| 03/21/1996 | WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | WO1996008563A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 03/21/1996 | WO1996008561A1 Method for detection of malfolded protein |
| 03/21/1996 | WO1996008557A1 Human inositol monophosphatase h1 |
| 03/21/1996 | WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 03/21/1996 | WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 03/21/1996 | WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 03/21/1996 | WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 03/21/1996 | WO1996008460A1 Legionella specific antibiotic, a microorganism producing the antibiotic and a process for producing the same |
| 03/21/1996 | WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 03/21/1996 | WO1996008269A1 Inhibition of human rotavirus infection |
| 03/21/1996 | WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type |
| 03/21/1996 | WO1995030757A3 Metalloproteases from fusarium and aspergillus having thermolysin-like activity |
| 03/21/1996 | WO1995020039A3 Customized proteases with altered transacylation activity |
| 03/21/1996 | DE4433307A1 Ein isoliertes Nuckleinsäurefragment und daraus abgeleitete Produkte An isolated Nuckleinsäurefragment and derived products |
| 03/21/1996 | CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 03/21/1996 | CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | CA2199719A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 03/21/1996 | CA2199707A1 Inhibition of human rotavirus infection |
| 03/21/1996 | CA2198361A1 Intracellular delivery of chemical agents to a specific cell type |
| 03/21/1996 | CA2198263A1 Method for detection of malfolded protein |
| 03/20/1996 | EP0702086A1 Process for producing antibiotics |
| 03/20/1996 | EP0702084A1 Recombinant retroviruses |
| 03/20/1996 | EP0702083A2 Polypeptides and fusion proteins that contain the UL57 open reading frame or the C-terminus of tegument protein pp150 from HCMV, corresponding oligonucleotides and diagnostic test kits |
| 03/20/1996 | EP0702082A1 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and dna base sequences encoding those sequences |
| 03/20/1996 | EP0701818A2 Therapeutic methods using catalytic antibodies |
| 03/20/1996 | EP0701696A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays |
| 03/20/1996 | EP0701628A1 Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path |
| 03/20/1996 | EP0701624A1 Method for the determination of salmonella |
| 03/20/1996 | EP0701622A1 Process for preparing glyoxylic acid/dialkyl aminomethylphosphonate mixtures |
| 03/20/1996 | EP0701616A1 Multicistronic expression of recombinant genes in bacterial cells |
| 03/20/1996 | EP0701613A1 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes |
| 03/20/1996 | EP0701612A1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS |
| 03/20/1996 | EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 03/20/1996 | EP0701606A1 Method of enhancing thrombolysis |
| 03/20/1996 | EP0701605A1 Improved enzymes and detergents containing them |
| 03/20/1996 | EP0701573A1 Genetically engineered immunoglobulins |
| 03/20/1996 | EP0701570A1 Thermoresistant alpha-1-antitrypsin mutein |